CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRSP Price/Volume Stats
| Current price | $46.85 | 52-week high | $91.10 |
| Prev. close | $45.39 | 52-week low | $37.55 |
| Day low | $45.03 | Volume | 1,108,400 |
| Day high | $47.50 | Avg. volume | 1,466,140 |
| 50-day MA | $47.24 | Dividend yield | N/A |
| 200-day MA | $59.30 | Market Cap | 3.98B |
CRSP Stock Price Chart Interactive Chart >
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
CRSP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Continue Researching CRSP
Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...